These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23864950)

  • 41. Weight status in persons with multiple sclerosis: implications for mobility outcomes.
    Pilutti LA; Dlugonski D; Pula JH; Motl RW
    J Obes; 2012; 2012():868256. PubMed ID: 23050129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
    Cadavid D; Cohen JA; Freedman MS; Goldman MD; Hartung HP; Havrdova E; Jeffery D; Kapoor R; Miller A; Sellebjerg F; Kinch D; Lee S; Shang S; Mikol D
    Mult Scler; 2017 Jan; 23(1):94-105. PubMed ID: 27003945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifocal visual evoked potentials and contrast sensitivity correlate with ganglion cell-inner plexiform layer thickness in multiple sclerosis.
    Narayanan D; Cheng H; Tang RA; Frishman LJ
    Clin Neurophysiol; 2019 Jan; 130(1):180-188. PubMed ID: 30473445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
    Wetter NC; Hubbard EA; Motl RW; Sutton BP
    Brain Behav; 2016 Mar; 6(3):e00440. PubMed ID: 26855828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance.
    Cederberg KLJ; Sikes EM; Bartolucci AA; Motl RW
    Gait Posture; 2019 Sep; 73():147-153. PubMed ID: 31326830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
    Sandroff BM; Pilutti LA; Motl RW
    NeuroRehabilitation; 2015; 37(1):149-55. PubMed ID: 26409700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis.
    Syc SB; Warner CV; Hiremath GS; Farrell SK; Ratchford JN; Conger A; Frohman T; Cutter G; Balcer LJ; Frohman EM; Calabresi PA
    Mult Scler; 2010 Jul; 16(7):829-39. PubMed ID: 20530512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS.
    Moster S; Wilson JA; Galetta SL; Balcer LJ
    J Neurol Sci; 2014 Aug; 343(1-2):105-9. PubMed ID: 24954088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physical activity and walking performance across the lifespan among adults with multiple sclerosis.
    Baird JF; Cederberg KLJ; Sikes EM; Silveira SL; Jeng B; Sasaki JE; Sandroff BM; Motl RW
    Mult Scler Relat Disord; 2019 Oct; 35():36-41. PubMed ID: 31302502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.
    Galetta KM; Graves J; Talman LS; Lile DJ; Frohman EM; Calabresi PA; Galetta SL; Balcer LJ
    J Neuroophthalmol; 2012 Jun; 32(2):116-23. PubMed ID: 22269944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.
    Nakamura M; Nakazawa T; Doi H; Hariya T; Omodaka K; Misu T; Takahashi T; Fujihara K; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1777-85. PubMed ID: 20300766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The six spot step test: a new measurement for walking ability in multiple sclerosis.
    Nieuwenhuis MM; Van Tongeren H; Sørensen PS; Ravnborg M
    Mult Scler; 2006 Aug; 12(4):495-500. PubMed ID: 16900764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.
    Bennett SE; Bromley LE; Fisher NM; Tomita MR; Niewczyk P
    Int J MS Care; 2017; 19(5):247-252. PubMed ID: 29070965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening-Minimum Rim Width or Peripapillary Retinal Nerve Fiber Layer Thicknesses.
    Nguyen J; Rothman A; Gonzalez N; Avornu A; Ogbuokiri E; Balcer LJ; Galetta SL; Frohman EM; Frohman T; Crainiceanu C; Calabresi PA; Saidha S
    J Neuroophthalmol; 2019 Dec; 39(4):444-450. PubMed ID: 30921169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical activity and peak oxygen consumption are associated with walking in multiple sclerosis.
    Hibner BA; Hilgenkamp TIM; Schroeder EC; Motl RW; Bollaert RE; Griffith G; Grigoriadis G; Baynard T; Fernhall B
    Mult Scler Relat Disord; 2020 May; 40():101941. PubMed ID: 31954226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
    Saidha S; Sotirchos ES; Ibrahim MA; Crainiceanu CM; Gelfand JM; Sepah YJ; Ratchford JN; Oh J; Seigo MA; Newsome SD; Balcer LJ; Frohman EM; Green AJ; Nguyen QD; Calabresi PA
    Lancet Neurol; 2012 Nov; 11(11):963-72. PubMed ID: 23041237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
    Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
    Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.